🇺🇸 FDA

Company profile · Sponsor

Amphastar

Amphastar France Pharmaceuticals

AMPH · NYSE pharma RANCHO CUCAMONGA, CA, EU
Pipeline
18
Drugs
8
Patents
8

Quick answer

Amphastar (AMPH) is a pharma company. headquartered in RANCHO CUCAMONGA, CA, EU. listed on NYSE. NovaPharmaNews links 18 pipeline programs, 8 drugs, and 8 patents to this profile..

Company facts

Ticker AMPH
Exchange NYSE
Company type pharma
Headquarters RANCHO CUCAMONGA, CA, EU
SEC CIK 0001297184

Pipeline (18)

Search pipeline →

  1. Armstrong Albuterol Sulfate Inhalation Aerosol

    Amphastar

    Asthma

    phase 3 small molecule terminated

    1 trial

  2. E004 (Epinephrine Inhalation Aerosol) HFA-MDI

    Amphastar

    Asthma

    phase 3 small molecule completed

    1 trial

  3. Epinephrine HFA-MDI (E004)

    Amphastar

    Asthma

    phase 3 small molecule completed

    1 trial

  4. I004

    Amphastar

    Pharmacokinetics

    phase 3 small molecule active

    2 trials

  5. Placebo

    Amphastar

    Asthma

    phase 3 small molecule completed

    1 trial

  6. albuterol (Armstrong Albuterol HFA)

    Amphastar

    Asthma

    phase 3 small molecule terminated

    1 trial

  7. albuterol HFA (Armstrong's)

    Amphastar

    Asthma

    phase 3 small molecule terminated

    1 trial

  8. epinephrine inhalation aerosol

    Amphastar

    Asthma

    phase 3 small molecule completed

    2 trials

  9. A006

    Amphastar

    Asthma

    phase 2 small molecule completed

    1 trial

  10. A006 DPI

    Amphastar

    Asthma

    phase 2 small molecule completed

    2 trials

  11. Albuterol DPI 25 mcg/inh

    Amphastar

    Asthma

    phase 2 small molecule completed

    1 trial

  12. Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation

    Amphastar

    Asthma

    phase 2 small molecule terminated

    1 trial

  13. Arm T1: Primatene Mist HFA

    Amphastar

    Asthma

    phase 2 small molecule completed

    1 trial

  14. E004 (epinephrine inhalation aerosol), 90 mcg/actuation

    Amphastar

    Asthma

    phase 2 small molecule terminated

    1 trial

  15. Epinephrine Inhalation Aerosol, HFA

    Amphastar

    Asthma

    phase 2 small molecule completed

    1 trial

  16. Hyaluronidase

    Amphastar

    Allergic Skin Reaction

    phase 2 small molecule completed

    1 trial

  17. albuterol inhalation powder

    Amphastar

    Asthma

    phase 2 small molecule completed

    1 trial

  18. Epinephrine (0.125 mg/inhalation)

    Amphastar

    Pharmacokinetics

    approved other completed

    1 trial

Drugs (8)

Search drugs →

  1. bupivacaine hydrochloride

    BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE

    SPINAL approved

  2. cosyntropin

    COSYNTROPIN

    INJECTION approved

  3. enoxaparin sodium

    INHIXA

    INJECTION approved

    B01AB05

  4. ganirelix acetate

    FYREMADEL

    INJECTION approved

  5. glucagon

    BAQSIMI

    INTRAVENOUS approved

    H04AA01

  6. hyaluronidase

    VITRAGAN

    INJECTION approved

  7. ketorolac tromethamine

    ACULAR LS

    NASAL approved

  8. teriparatide

    SONDELBAY

    SUBCUTANEOUS approved

    H05AA02

Patents (8)

Search patents →

  1. US 12383516

    Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12370241

    Nasal powder formulation for treatment of hypoglycemia

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12325732

    Pro-insulin aspart structure and method for preparing insulin aspart

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12226456

    Nasal powder formulation for treatment of hypoglycemia

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11938089

    Medication delivery systems and methods

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11524987

    Highly purified recombinant human insulin (RHI) API and methods of producing the same

    Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11446360

    High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10851146

    Method for preparing liraglutide intermediate polypeptide

    Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Amphastar?

Amphastar (AMPH) is a pharma company. headquartered in RANCHO CUCAMONGA, CA, EU. listed on NYSE. NovaPharmaNews links 18 pipeline programs, 8 drugs, and 8 patents to this profile..

What pipeline programs does Amphastar sponsor?

We track 18 ClinicalTrials.gov-linked programs for Amphastar, including Armstrong Albuterol Sulfate Inhalation Aerosol and 17 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Amphastar company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.